Pranati Perati
patient
Pranati Perati, a molecular biologist from Northern California, began taking daraxonrasib in 2023 after other treatments failed, and she has experienced a halt in tumor growth, allowing her to live a fulfilling life despite the challenges of her illness.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Greece:
Pranati Perati began taking daraxonrasib in 2023 when previous treatments failed.
6
Debbie Orcutt
Andrew Nixon
Brian Wolpin
Lei Zheng
Kevan Shokat
Mark Goldsmith
Anna Berkenblit
Marty Makary
Kathimerini: Πειραματικό χάπι γεννά ελπίδες για έναν από τους πιο θανατηφόρους καρκίνους